| Application number | Title of the application | Filing Date | Status |
|---|
| 09/403296 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES | Oct 17, 1999 | Abandoned |
Array
(
[id] => 7643754
[patent_doc_number] => 06429286
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Immunoregulatory molecules for costimulatory signal transduction'
[patent_app_type] => B1
[patent_app_number] => 09/403089
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9020
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429286.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403089
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403089 | Immunoregulatory molecules for costimulatory signal transduction | Oct 14, 1999 | Issued |
| 09/413136 | NOVEL TH2-SPECIFIC MOLECULES AND USES THEREOF | Oct 5, 1999 | Abandoned |
Array
(
[id] => 4403229
[patent_doc_number] => 06238666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'RANTES homolog antibody'
[patent_app_type] => 1
[patent_app_number] => 9/395918
[patent_app_country] => US
[patent_app_date] => 1999-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16386
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/238/06238666.pdf
[firstpage_image] =>[orig_patent_app_number] => 395918
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/395918 | RANTES homolog antibody | Sep 13, 1999 | Issued |
| 09/394767 | TRANSMEMBRANE POLYPETIDE EXPRESSED BY LYMPHOCYTES | Sep 12, 1999 | Abandoned |
Array
(
[id] => 1282731
[patent_doc_number] => 06638506
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to FcRIII'
[patent_app_type] => B1
[patent_app_number] => 09/367011
[patent_app_country] => US
[patent_app_date] => 1999-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2504
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/638/06638506.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367011
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367011 | Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using antibodies to FcRIII | Sep 6, 1999 | Issued |
Array
(
[id] => 6618355
[patent_doc_number] => 20020086012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'COSTIMULATION OF T-CELL PROLIFERATION BY A CHIMERIC BISPECIFIC COSTIMULATORY PROTEIN'
[patent_app_type] => new
[patent_app_number] => 09/380415
[patent_app_country] => US
[patent_app_date] => 1999-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6576
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086012.pdf
[firstpage_image] =>[orig_patent_app_number] => 09380415
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380415 | COSTIMULATION OF T-CELL PROLIFERATION BY A CHIMERIC BISPECIFIC COSTIMULATORY PROTEIN | Aug 30, 1999 | Abandoned |
Array
(
[id] => 4333293
[patent_doc_number] => 06333033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Autoantibody inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/384036
[patent_app_country] => US
[patent_app_date] => 1999-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7469
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333033.pdf
[firstpage_image] =>[orig_patent_app_number] => 384036
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384036 | Autoantibody inhibitors | Aug 25, 1999 | Issued |
| 09/383315 | EXPRESSION AND EXPORT OF ANGIOGENESIS INHIBITORS AS IMMUNOFUSINS | Aug 24, 1999 | Abandoned |
Array
(
[id] => 1395722
[patent_doc_number] => 06545124
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Peptide linkers for covalent linking polypeptide cell modulators'
[patent_app_type] => B1
[patent_app_number] => 09/382738
[patent_app_country] => US
[patent_app_date] => 1999-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9088
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545124.pdf
[firstpage_image] =>[orig_patent_app_number] => 09382738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/382738 | Peptide linkers for covalent linking polypeptide cell modulators | Aug 24, 1999 | Issued |
Array
(
[id] => 1489226
[patent_doc_number] => 06416757
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Tumor necrosis factor antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/364039
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 41
[patent_no_of_words] => 13649
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/416/06416757.pdf
[firstpage_image] =>[orig_patent_app_number] => 09364039
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364039 | Tumor necrosis factor antibodies | Jul 29, 1999 | Issued |
| 09/362812 | METHODS OF PREVENTING IMMUNE-MEDIATED ABORTION BY INHIBITING COSTIMULATORY SIGNALS | Jul 27, 1999 | Abandoned |
Array
(
[id] => 5987900
[patent_doc_number] => 20020099176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'ANTIBODIES TO HUMAN G-PROTEIN CHEMOKINE RECEPTOR HDGNR10 (CCR5RECEPTOR)'
[patent_app_type] => new
[patent_app_number] => 09/339912
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12725
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09339912
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339912 | Antibodies to human G-protein chemokine receptor HDGNR10 (CCR5receptor) | Jun 24, 1999 | Issued |
Array
(
[id] => 1435767
[patent_doc_number] => 06355410
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Method of reducing cell proliferation by inhibiting the Na/H exchanger and inducing apoptosis'
[patent_app_type] => B1
[patent_app_number] => 09/325444
[patent_app_country] => US
[patent_app_date] => 1999-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4988
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355410.pdf
[firstpage_image] =>[orig_patent_app_number] => 09325444
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/325444 | Method of reducing cell proliferation by inhibiting the Na/H exchanger and inducing apoptosis | Jun 2, 1999 | Issued |
Array
(
[id] => 5950782
[patent_doc_number] => 20020006405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'SEPSIS REMEDY COMPRISING ANTI-IL-8 ANTIBODY AS ACTIVE INGREDIENT'
[patent_app_type] => new
[patent_app_number] => 09/284781
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10314
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006405.pdf
[firstpage_image] =>[orig_patent_app_number] => 09284781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/284781 | SEPSIS REMEDY COMPRISING ANTI-IL-8 ANTIBODY AS ACTIVE INGREDIENT | May 31, 1999 | Abandoned |
Array
(
[id] => 1596141
[patent_doc_number] => 06384203
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)'
[patent_app_type] => B1
[patent_app_number] => 09/310463
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09310463
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310463 | Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) | May 11, 1999 | Issued |
| 09/293042 | ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY CO-ADMINISTRATION WITH PROSTAGLANDIN INHIBITOR | Apr 15, 1999 | Abandoned |
| 09/293245 | AGP-1 FUSION PROTEIN COMPOSITIONS | Apr 15, 1999 | Abandoned |
Array
(
[id] => 1448910
[patent_doc_number] => 06455042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Method of treating ulcerative colitis or crohn\'s disease by administering an antibody toE7 integrin'
[patent_app_type] => B1
[patent_app_number] => 09/293238
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19893
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09293238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293238 | Method of treating ulcerative colitis or crohn's disease by administering an antibody toE7 integrin | Apr 15, 1999 | Issued |
| 09/292217 | ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY CO-ADMINISTRATION WITH ANGIOGENESIS INHIBITOR | Apr 14, 1999 | Abandoned |
